All In Biotech

Drug Trial Radar · NCT04005417

Meta-analysis of Stannous Fluoride Dentifrice and the Effects on Dentine Hypersensitivity

Bioavailable Stannous Fluoride Dentifrice Meta-Analyses: Effects on Dentine Hypersensitivity and Enamel Erosion

Last checked: Nov 20, 2026Latest source record: Jul 2, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

1,036

Actual

Start

Jan 8, 2018

Primary completion

Nov 30, 2018

Study completion Nov 30, 2018

Sponsor

Lead sponsor
Procter and GambleIndustry
Sponsor type
Industry
First posted
Jul 2, 2019

More drug trials from this sponsor

Design

Study type
Observational
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The aim of this 11 study analysis was to compare the effect of bioavailable stannous fluoride (SnF2) on dentine hypersensitivity versus a positive or negative control dentifrice.

Conditions

  • Dentine Hypersensitivity

Interventions

  • Stannous fluoride dentifriceDrug

    Stannous fluoride (0.454%) dentifrice

  • Positive control dentifriceDrug

    Positive control dentifrice containing potassium nitrate or arginine.

  • Negative control dentifriceDrug

    Negative control dentifrice containing either sodium fluoride (0.243%) or sodium monofluorophosphate (0.76%)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from Baseline Air ChallengeTime frame: Up to 8 weeks
  2. Change from Baseline in Tactile ThresholdTime frame: Up to 8 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Multiple P&G Investigation Clinical Sites

    Cincinnati, Ohio

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.